NO992869L - 1-Fenylalkyl-1,2,3,6-tetrahydropyridiner for behandling av Alzheimer's sykdom - Google Patents

1-Fenylalkyl-1,2,3,6-tetrahydropyridiner for behandling av Alzheimer's sykdom

Info

Publication number
NO992869L
NO992869L NO992869A NO992869A NO992869L NO 992869 L NO992869 L NO 992869L NO 992869 A NO992869 A NO 992869A NO 992869 A NO992869 A NO 992869A NO 992869 L NO992869 L NO 992869L
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
amino
pct
group
Prior art date
Application number
NO992869A
Other languages
English (en)
Other versions
NO992869D0 (no
NO312720B1 (no
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO992869L publication Critical patent/NO992869L/no
Publication of NO992869D0 publication Critical patent/NO992869D0/no
Publication of NO312720B1 publication Critical patent/NO312720B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
NO19992869A 1996-12-13 1999-06-11 1-fenylalkyl-1,2,3,6-tetrahydropyridiner, fremgangsmåte for fremstilling derav og farmasöytisk preparat NO312720B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615335A FR2757160B1 (fr) 1996-12-13 1996-12-13 1-phenylalkyl-1,2,3,6-tetrahydropyridines
PCT/FR1997/002286 WO1998025903A1 (fr) 1996-12-13 1997-12-12 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer

Publications (3)

Publication Number Publication Date
NO992869L true NO992869L (no) 1999-06-11
NO992869D0 NO992869D0 (no) 1999-06-11
NO312720B1 NO312720B1 (no) 2002-06-24

Family

ID=9498641

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992869A NO312720B1 (no) 1996-12-13 1999-06-11 1-fenylalkyl-1,2,3,6-tetrahydropyridiner, fremgangsmåte for fremstilling derav og farmasöytisk preparat

Country Status (32)

Country Link
US (1) US6034090A (no)
EP (1) EP0950048B1 (no)
JP (1) JP3881384B2 (no)
KR (1) KR100560358B1 (no)
CN (1) CN1129579C (no)
AT (1) ATE202561T1 (no)
AU (1) AU730143B2 (no)
BR (1) BR9713916A (no)
CA (1) CA2275353C (no)
CY (1) CY2274B1 (no)
CZ (1) CZ289789B6 (no)
DE (1) DE69705429T2 (no)
DK (1) DK0950048T3 (no)
EE (1) EE03763B1 (no)
ES (1) ES2160977T3 (no)
FR (1) FR2757160B1 (no)
GR (1) GR3036643T3 (no)
HK (1) HK1023997A1 (no)
HU (1) HU224347B1 (no)
IL (1) IL130003A (no)
IS (1) IS1969B (no)
NO (1) NO312720B1 (no)
NZ (1) NZ336033A (no)
PL (1) PL190789B1 (no)
PT (1) PT950048E (no)
RS (1) RS49807B (no)
RU (1) RU2189975C2 (no)
SI (1) SI0950048T1 (no)
SK (1) SK283331B6 (no)
TR (1) TR199901291T2 (no)
UA (1) UA52707C2 (no)
WO (1) WO1998025903A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
FR2832405B1 (fr) * 2001-11-19 2004-12-10 Sanofi Synthelabo Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds

Also Published As

Publication number Publication date
JP3881384B2 (ja) 2007-02-14
BR9713916A (pt) 2000-02-29
DE69705429D1 (de) 2001-08-02
PT950048E (pt) 2001-12-28
AU730143B2 (en) 2001-03-01
DK0950048T3 (da) 2001-09-24
NO992869D0 (no) 1999-06-11
HU224347B1 (hu) 2005-08-29
TR199901291T2 (xx) 1999-10-21
IL130003A (en) 2004-09-27
HUP0001185A3 (en) 2002-10-28
CZ211399A3 (cs) 2000-09-13
KR100560358B1 (ko) 2006-03-14
IL130003A0 (en) 2000-02-29
SK283331B6 (sk) 2003-06-03
CA2275353C (en) 2007-05-22
CY2274B1 (en) 2003-07-04
CN1129579C (zh) 2003-12-03
EE9900237A (et) 1999-12-15
HUP0001185A2 (hu) 2000-10-28
CZ289789B6 (cs) 2002-04-17
ES2160977T3 (es) 2001-11-16
WO1998025903A1 (fr) 1998-06-18
RU2189975C2 (ru) 2002-09-27
JP2001505902A (ja) 2001-05-08
US6034090A (en) 2000-03-07
YU24399A (sh) 2001-07-10
FR2757160A1 (fr) 1998-06-19
CA2275353A1 (en) 1998-06-18
IS1969B (is) 2004-12-15
NZ336033A (en) 2000-12-22
EP0950048A1 (fr) 1999-10-20
CN1240427A (zh) 2000-01-05
KR20000069422A (ko) 2000-11-25
EE03763B1 (et) 2002-06-17
UA52707C2 (uk) 2003-01-15
RS49807B (sr) 2008-08-07
GR3036643T3 (en) 2001-12-31
NO312720B1 (no) 2002-06-24
PL190789B1 (pl) 2006-01-31
AU5489398A (en) 1998-07-03
SK78699A3 (en) 2000-01-18
IS5075A (is) 1999-06-10
FR2757160B1 (fr) 1999-03-12
DE69705429T2 (de) 2002-05-16
PL334071A1 (en) 2000-01-31
ATE202561T1 (de) 2001-07-15
SI0950048T1 (en) 2001-10-31
EP0950048B1 (fr) 2001-06-27
HK1023997A1 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
CA2225746A1 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
HUP0301690A2 (hu) Szinergikus eljárások és készítmények rák kezelésére
AU4437896A (en) Piperidine derivatives having tachykinin antagonist activity
NO995245D0 (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for Õ behandle sykdommer som bevirker demyelinisering
NO992869D0 (no) 1-Fenylalkyl-1,2,3,6-tetrahydropyridiner for behandling av Alzheimer's sykdom
HUP0100098A2 (hu) Hatóanyagokként, különösen tetrahidro-piridinek és acetil-kolin-észteráz gátlók kombinációját tartalmazó öregkori dementia, különösen Alzheimer típusú dementia kezelésére szolgáló gyógyszerkészítmények
IL112415A (en) 3R* 4s* -3-Ú4-(4-fluorophenyl)4-hydroxy-piperidin-1-yl¾chroman-4,7-diol and pharmaceutical compositions comprising them
PL334073A1 (en) Diphenylalkyl tetrahydropyridines, method of obtaining them and compositions containing such compounds